The transaction includes $70m in cash and a $20m retained equity position for Nektar in a new Ampersand portfolio company.
After a protracted rough patch—which has included layoffs, partnership terminations and lawsuits—San Francisco’s Nektar ...
Therapeutics announced that it has entered into a definitive agreement to sell its Huntsville, Alabama manufacturing facility and ...
Nektar Therapeutics (Nasdaq: NKTR), a global biotechnology company focused on the discovery and development of novel therapies to treat autoimmune disorders, today announced that it has entered into a ...
(RTTNews) - Nektar Therapeutics (NKTR), Monday announced a decision to sell its Alabama-based commercial-scale manufacturing facility and PEGylation reagent supply business to Ampersand Capital ...
World Ampersand Day is celebrated annually on September 8. This year it falls on a Sunday. The day acknowledges the use of the symbol, embraces its aesthetic appeal, and encourages people to use ...
Ampersand reaches 1150 bikes on the roads of Nairobi Expansion underscores company's commitment to cutting carbon emissions and driving clean economic prosperity across Africa Nairobi – Ampersand, ...